These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8841027)

  • 1. Response of aleukemic granulocytic sarcoma to all-trans-retinoic acid plus interferon alfa-2a.
    Toma S; Palumbo R; Giordano D; Arcuri T; Regazzi MB
    J Natl Cancer Inst; 1996 Oct; 88(20):1494-5. PubMed ID: 8841027
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Response of aleukemic granulocytic sarcoma to all-trans-retinoic acid plus interferon alfa-2a.
    Fleming GF; Waggoner SE; Wu S; Rotmensch J; Conley BA
    J Natl Cancer Inst; 1997 Jan; 89(2):172-3. PubMed ID: 8998189
    [No Abstract]   [Full Text] [Related]  

  • 3. A phase II evaluation of all-trans-retinoic acid plus interferon alfa-2a in stage IV melanoma: a Southwest Oncology Group study.
    Sondak VK; Liu PY; Flaherty LE; Fletcher WS; Periman P; Gandara DR; Taylor SA; Balcerzak SP; Meyskens FL
    Cancer J Sci Am; 1999; 5(1):41-7. PubMed ID: 10188060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of granulocytic sarcoma with alpha-interferon and disodium pamidronate at presentation of chronic myeloid leukemia.
    Stagno F; Guglielmo P; Consoli U; Pafumi M; Giustolisi R
    Acta Haematol; 2001; 105(2):116-7. PubMed ID: 11408718
    [No Abstract]   [Full Text] [Related]  

  • 5. Modulation of all-trans-retinoic acid administered on intermittent schedule by alpha-interferon 2a in a patient with AIDS-related Kaposi's sarcoma.
    Toma S; Iacona I; Palumbo R; Moresco L; Raffo P; Regazzi MB
    AIDS; 1996 Aug; 10(9):1049-50. PubMed ID: 8853745
    [No Abstract]   [Full Text] [Related]  

  • 6. Phase II study of all-trans retinoic acid in the accelerated phase or early blastic phase of chronic myeloid leukemia: a study of the Eastern Cooperative Oncology Group (E1993).
    Dutcher JP; Lee S; Gallagher RE; Makary AZ; Hines JD; Londer H; Farnen JP; Bennett JM; Paietta E; Rowe JM; Goloubeva O; Wiernik PH;
    Leuk Lymphoma; 2005 Mar; 46(3):377-85. PubMed ID: 15621827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensive consolidation versus oral maintenance therapy in patients 61 years or older with acute myeloid leukemia in first remission: results of second randomization of the AML HD98-B treatment Trial.
    Schlenk RF; Fröhling S; Hartmann F; Fischer JT; Glasmacher A; Del Valle F; Götze K; Nerl C; Schoch R; Pralle H; Mergenthaler HG; Hensel M; Koller E; Kirchen H; Matzdorff A; Salwender H; Biedermann HG; Kremers S; Haase D; Benner A; Döhner K; Döhner H
    Leukemia; 2006 Apr; 20(4):748-50. PubMed ID: 16437135
    [No Abstract]   [Full Text] [Related]  

  • 8. [Combination of interferon-alpha and all-trans-retinoic acid as a treatment for maintaining remission in high-risk group patients with acute myeloid leukemia].
    Parovichnikova EN; Savchenko VG; Isaev VG; Demidova IA; Ol'shanskaia IuV; Lapin VA; Cherepanova VV; Rekhtman GB; Perekatova TN
    Ter Arkh; 2001; 73(7):15-20. PubMed ID: 11523403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I/II study of intermittent all-trans-retinoic acid, alone and in combination with interferon alfa-2a, in patients with epidemic Kaposi's sarcoma.
    Bailey J; Pluda JM; Foli A; Saville MW; Bauza S; Adamson PC; Murphy RF; Cohen RB; Broder S; Yarchoan R
    J Clin Oncol; 1995 Aug; 13(8):1966-74. PubMed ID: 7636537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 13-cis-retinoic acid plus interferon-alpha 2a in locally advanced squamous cell carcinoma of the cervix.
    Lippman SM; Kavanagh JJ; Paredes-Espinoza M; Delgadillo-Madrueño F; Paredes-Casillas P; Hong WK; Massimini G; Holdener EE; Krakoff IH
    J Natl Cancer Inst; 1993 Mar; 85(6):499-500. PubMed ID: 8445678
    [No Abstract]   [Full Text] [Related]  

  • 11. Rapid response of refractory ocular surface dysplasia to combination treatment with topical all-trans retinoic acid and interferon alfa-2b.
    Skippen B; Tsang HH; Assaad NN; Coroneo MT
    Arch Ophthalmol; 2010 Oct; 128(10):1368-9. PubMed ID: 20938011
    [No Abstract]   [Full Text] [Related]  

  • 12. Pilot study of combined therapy with interferon-alpha, arabinosyl cytosine and all-trans retinoic acid in patients with chronic myeloid leukemia in the chronic phase.
    Russo D; Marin L; Bertone A; Tiribelli M; Testoni N; Martinelli G
    Haematologica; 1999 Feb; 84(2):185-7. PubMed ID: 10091422
    [No Abstract]   [Full Text] [Related]  

  • 13. Response to 13-cis-retinoic acid plus interferon alfa-2a in two patients with therapy-refractory advanced renal cell carcinoma.
    Buer J; Probst M; Ganser A; Atzpodien J
    J Clin Oncol; 1995 Oct; 13(10):2679-80. PubMed ID: 7595723
    [No Abstract]   [Full Text] [Related]  

  • 14. Randomized phase II/III trial of interferon Alfa-2a with and without 13-cis-retinoic acid in patients with progressive metastatic renal cell Carcinoma: the European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group (EORTC 30951).
    Aass N; De Mulder PH; Mickisch GH; Mulders P; van Oosterom AT; van Poppel H; Fossa SD; de Prijck L; Sylvester RJ
    J Clin Oncol; 2005 Jun; 23(18):4172-8. PubMed ID: 15961764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase 1/2 clinical trial of interferon alpha2b and weekly liposome-encapsulated all-trans retinoic acid in patients with advanced renal cell carcinoma.
    Boorjian SA; Milowsky MI; Kaplan J; Albert M; Cobham MV; Coll DM; Mongan NP; Shelton G; Petrylak D; Gudas LJ; Nanus DM
    J Immunother; 2007 Sep; 30(6):655-62. PubMed ID: 17667529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 13-Cis-retinoic acid plus interferon-alpha 2a in recurrent respiratory papillomatosis.
    Lippman SM; Donovan DT; Frankenthaler RA; Weber RS; Earley CL; Hong WK; Goepfert H
    J Natl Cancer Inst; 1994 Jun; 86(11):859-61. PubMed ID: 8182767
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of the chronic phase of chronic myeloid leukemia with an intermittent schedule of recombinant interferon alfa-2b and cytarabine: results from CALGB study 9013.
    Silver RT; Peterson BL; Szatrowski TP; Powell BL; Stock W; Carroll AJ; Bloomfield CD; Schiffer CA; Larson RA
    Leuk Lymphoma; 2003 Jan; 44(1):39-48. PubMed ID: 12691141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulocytic sarcoma: a diagnosis to be considered in unusual lymphoma syndromes.
    Mansi JL; Selby PJ; Carter RL; Powles RL; McElwain TJ
    Postgrad Med J; 1987 Jun; 63(740):447-9. PubMed ID: 3481072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 13-cis retinoic acid and interferon alfa-2a in the treatment of metastatic renal cell carcinoma.
    Casali A; Sega FM; Casali M; Serrone L; Terzoli E
    J Exp Clin Cancer Res; 1998 Jun; 17(2):227-9. PubMed ID: 9700585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase III trial of interferon alfa-2a with or without 13-cis-retinoic acid for patients with advanced renal cell carcinoma.
    Motzer RJ; Murphy BA; Bacik J; Schwartz LH; Nanus DM; Mariani T; Loehrer P; Wilding G; Fairclough DL; Cella D; Mazumdar M
    J Clin Oncol; 2000 Aug; 18(16):2972-80. PubMed ID: 10944130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.